R1487

CAS No. 449811-92-1

R1487( —— )

Catalog No. M20961 CAS No. 449811-92-1

R1487 is an orally bioavailable and highly selective p38α mitogen-activated protein kinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 268 Get Quote
10MG 408 Get Quote
25MG 672 Get Quote
50MG 945 Get Quote
100MG 1278 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    R1487
  • Note
    Research use only, not for human use.
  • Brief Description
    R1487 is an orally bioavailable and highly selective p38α mitogen-activated protein kinase inhibitor.
  • Description
    R1487 is an orally bioavailable and highly selective p38α mitogen-activated protein kinase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    p38α
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    449811-92-1
  • Formula Weight
    388.36
  • Molecular Formula
    C19H18F2N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dunford E C Herbst E A Jeoung N H et al. PDH activation during in vitro muscle contractions in PDH kinase 2 knockout mice: Effect of PDH kinase 1 compensation[J]. American Journal of Physiology Regulatory Integrative & Comparative Physiology 2011 300(6):R1487.
molnova catalog
related products
  • E6446 dihydrochlorid...

    E6446 dihydrochloride is a novel synthetic antagonist for nucleic acid-sensing TLRs; potently suppressed DNA stimulation of HEK:TLR9 cells with IC50 of 10 nM.

  • Doramapimod

    A highly potent p38 MAPK inhibitor with Kd of 0.1 nM.

  • Kamebakaurine

    Kamebakaurin has the ability to protect the liver from APAP-induced hepatotoxicity, presumably by both inhibiting the inflammatory response and oxidative stress.